The latest study on Infectious Diseases Market by Read Market Research provides a detailed summary and overview of the global market. The base year considered in this report is considered 2020 whereas information for 2021 is estimated and forecast from 2022 till 2027. The CAGR (Compound Annual Growth Rate) period of this report is 2021-2027. The Global Infectious Diseases Market is valued at USD XX Million in the year 2020 and is estimated to grow at USD XX Million by the end of year 2027.The report will shed light on very important growth aspect of Infectious Diseases and is a must have data for all the companies, investors, decision makers, top level executives and readers.
The segmental analysis of the report provides detailed analysis on Revenue, Growth, Forecast By Region, Type and Applications for the period 2016-2027.
The major vendors covered:
F. Hoffmann-La Roche
Gilead Sciences
GlaxoSmithKline
Johnson & Johnson
Merck
Pfizer
AbbVie
Astellas Pharma
AstraZeneca
Bayer
Bristol-Myers Squibb
Chimerix Pharmaceuticals
Cubist
Eli Lilly
Isis Pharmaceuticals
Mitsubishi Tanabe Pharma
Novartis
Sanofi
Vertex
Infectious Diseases Market Analysis By Type Segment:
Antibacterial drugs
Antiviral drugs
Antifungal drugs
Antiparasitic drugs
Infectious Diseases Market Analysis By Application Segment:
Acquired Immune Deficiency Syndrome
Hepatitis B
Hepatitis C
Human Papillomavirus
Hospital acquired Methicillin-resistant Staphylococcus aureus infection
Chlamydia trachomatis and Neisseria Gonorrhea
Infectious Diseases Market Analysis By Regions (Countries):
The Infectious Diseases Market has been thoroughly researched with the help of Primary and Secondary Research and has been validated by conduction interviews with industry experts across all the regions. As it is global study, we have included all the major regions.
Bottom Up approach has been used to derive and define the market size and shares of regions. Regions such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. has been taken into consideration while deriving the market size and shares of regions.
Key Details of Regions and Countries of Infectious Diseases Report:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
Key data provided:
Market Size of Regions
Market Share of Regions
Compound Annual Growth Rate (CAGR)
Historic Data From 2016-2020
Forecast Data From 2021-2027
Competitive Landscape of Infectious Diseases Market:
Infectious Diseases market competitive landscape analysis sheds light on the current market structure by players. The report will help the readers to understand some most important questions of the global market.
Key Questions Answered in Competitive Landscape-
List of Key Players
Revenue By players
Market share of players
Product Offerings
The study objectives are:
To analyze and research the Infectious Diseases Market status and future forecast.
To present the key Infectious Diseases Market analysis of companies and present revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Infectious Diseases Market Size Growth Rate by Type (2016-2027)
1.4.2 Antibacterial drugs
1.4.3 Antiviral drugs
1.4.4 Antifungal drugs
1.4.5 Antiparasitic drugs
1.5 Market by Application
1.5.1 Global Infectious Diseases Market Share by Application (2016-2027)
1.5.2 Acquired Immune Deficiency Syndrome
1.5.3 Hepatitis B
1.5.4 Hepatitis C
1.5.5 Human Papillomavirus
1.5.6 Hospital acquired Methicillin-resistant Staphylococcus aureus infection
1.5.7 Chlamydia trachomatis and Neisseria Gonorrhea
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Infectious Diseases Market Size
2.2 Infectious Diseases Growth Trends by Regions
2.2.1 Infectious Diseases Market Size by Regions (2016-2027)
2.2.2 Infectious Diseases Market Share by Regions (2016-2020)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Infectious Diseases Market Size by Manufacturers
3.1.1 Global Infectious Diseases Revenue by Manufacturers (2020)
3.1.2 Global Infectious Diseases Revenue Market Share by Manufacturers (2020)
3.1.3 Global Infectious Diseases Market Concentration Ratio (CR5 and HHI)
3.2 Infectious Diseases Key Players Head office and Area Served
3.3 Key Players Infectious Diseases Product/Solution/Service
3.4 Date of Enter into Infectious Diseases Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Infectious Diseases Market Size by Type (2016-2020)
4.2 Global Infectious Diseases Market Size by Application (2016-2020)
5 United States
5.1 United States Infectious Diseases Market Size (2016-2020)
5.2 Infectious Diseases Key Players in United States
5.3 United States Infectious Diseases Market Size by Type
5.4 United States Infectious Diseases Market Size by Application
6 Europe
6.1 Europe Infectious Diseases Market Size (2016-2020)
6.2 Infectious Diseases Key Players in Europe
6.3 Europe Infectious Diseases Market Size by Type
6.4 Europe Infectious Diseases Market Size by Application
7 China
7.1 China Infectious Diseases Market Size (2016-2020)
7.2 Infectious Diseases Key Players in China
7.3 China Infectious Diseases Market Size by Type
7.4 China Infectious Diseases Market Size by Application
8 Japan
8.1 Japan Infectious Diseases Market Size (2016-2020)
8.2 Infectious Diseases Key Players in Japan
8.3 Japan Infectious Diseases Market Size by Type
8.4 Japan Infectious Diseases Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Infectious Diseases Market Size (2016-2020)
9.2 Infectious Diseases Key Players in Southeast Asia
9.3 Southeast Asia Infectious Diseases Market Size by Type
9.4 Southeast Asia Infectious Diseases Market Size by Application
10 India
10.1 India Infectious Diseases Market Size (2016-2020)
10.2 Infectious Diseases Key Players in India
10.3 India Infectious Diseases Market Size by Type
10.4 India Infectious Diseases Market Size by Application
11 Central & South America
11.1 Central & South America Infectious Diseases Market Size (2016-2020)
11.2 Infectious Diseases Key Players in Central & South America
11.3 Central & South America Infectious Diseases Market Size by Type
11.4 Central & South America Infectious Diseases Market Size by Application
12 International Players Profiles
12.1 F. Hoffmann-La Roche
12.1.1 F. Hoffmann-La Roche Company Details
12.1.2 Company Description and Business Overview
12.1.3 Infectious Diseases Introduction
12.1.4 F. Hoffmann-La Roche Revenue in Infectious Diseases Business (2020)
12.1.5 F. Hoffmann-La Roche Recent Development
12.2 Gilead Sciences
12.2.1 Gilead Sciences Company Details
12.2.2 Company Description and Business Overview
12.2.3 Infectious Diseases Introduction
12.2.4 Gilead Sciences Revenue in Infectious Diseases Business (2020)
12.2.5 Gilead Sciences Recent Development
12.3 GlaxoSmithKline
12.3.1 GlaxoSmithKline Company Details
12.3.2 Company Description and Business Overview
12.3.3 Infectious Diseases Introduction
12.3.4 GlaxoSmithKline Revenue in Infectious Diseases Business (2020)
12.3.5 GlaxoSmithKline Recent Development
12.4 Johnson & Johnson
12.4.1 Johnson & Johnson Company Details
12.4.2 Company Description and Business Overview
12.4.3 Infectious Diseases Introduction
12.4.4 Johnson & Johnson Revenue in Infectious Diseases Business (2020)
12.4.5 Johnson & Johnson Recent Development
12.5 Merck
12.5.1 Merck Company Details
12.5.2 Company Description and Business Overview
12.5.3 Infectious Diseases Introduction
12.5.4 Merck Revenue in Infectious Diseases Business (2020)
12.5.5 Merck Recent Development
12.6 Pfizer
12.6.1 Pfizer Company Details
12.6.2 Company Description and Business Overview
12.6.3 Infectious Diseases Introduction
12.6.4 Pfizer Revenue in Infectious Diseases Business (2020)
12.6.5 Pfizer Recent Development
12.7 AbbVie
12.7.1 AbbVie Company Details
12.7.2 Company Description and Business Overview
12.7.3 Infectious Diseases Introduction
12.7.4 AbbVie Revenue in Infectious Diseases Business (2020)
12.7.5 AbbVie Recent Development
12.8 Astellas Pharma
12.8.1 Astellas Pharma Company Details
12.8.2 Company Description and Business Overview
12.8.3 Infectious Diseases Introduction
12.8.4 Astellas Pharma Revenue in Infectious Diseases Business (2020)
12.8.5 Astellas Pharma Recent Development
12.9 AstraZeneca
12.9.1 AstraZeneca Company Details
12.9.2 Company Description and Business Overview
12.9.3 Infectious Diseases Introduction
12.9.4 AstraZeneca Revenue in Infectious Diseases Business (2020)
12.9.5 AstraZeneca Recent Development
12.10 Bayer
12.10.1 Bayer Company Details
12.10.2 Company Description and Business Overview
12.10.3 Infectious Diseases Introduction
12.10.4 Bayer Revenue in Infectious Diseases Business (2020)
12.10.5 Bayer Recent Development
12.11 Bristol-Myers Squibb
12.12 Chimerix Pharmaceuticals
12.13 Cubist
12.14 Eli Lilly
12.15 Isis Pharmaceuticals
12.16 Mitsubishi Tanabe Pharma
12.17 Novartis
12.18 Sanofi
12.19 Vertex
13 Market Forecast 2021-2027
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2021-2027)
13.10 Market Size Forecast by Application (2021-2027)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
List of Tables and Figures
Table Infectious Diseases Key Market Segments
Table Key Players Infectious Diseases Covered
Table Global Infectious Diseases Market Size Growth Rate by Type 2016-2027 (Million US$)
Figure Global Infectious Diseases Market Size Market Share by Type 2016-2027
Figure Antibacterial drugs Figures
Table Key Players of Antibacterial drugs
Figure Antiviral drugs Figures
Table Key Players of Antiviral drugs
Figure Antifungal drugs Figures
Table Key Players of Antifungal drugs
Figure Antiparasitic drugs Figures
Table Key Players of Antiparasitic drugs
Table Global Infectious Diseases Market Size Growth by Application 2016-2027 (Million US$)
Figure Acquired Immune Deficiency Syndrome Case Studies
Figure Hepatitis B Case Studies
Figure Hepatitis C Case Studies
Figure Human Papillomavirus Case Studies
Figure Hospital acquired Methicillin-resistant Staphylococcus aureus infection Case Studies
Figure Chlamydia trachomatis and Neisseria Gonorrhea Case Studies
Figure Infectious Diseases Report Years Considered
Table Global Infectious Diseases Market Size 2016-2027 (Million US$)
Figure Global Infectious Diseases Market Size and Growth Rate 2016-2027 (Million US$)
Table Global Infectious Diseases Market Size by Regions 2016-2027 (Million US$)
Table Global Infectious Diseases Market Size by Regions 2016-2020 (Million US$)
Table Global Infectious Diseases Market Share by Regions 2016-2020
Figure Global Infectious Diseases Market Share by Regions 2016-2020
Figure Global Infectious Diseases Market Share by Regions 2020
Table Market Top Trends
Table Global Infectious Diseases Revenue by Manufacturers (2020) (Million US$)
Table Global Infectious Diseases Market Share by Manufacturers (2020)
Figure Global Infectious Diseases Market Share by Manufacturers in 2020
Table Global Infectious Diseases Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Infectious Diseases Product/Solution/Service
Table Date of Enter into Infectious Diseases Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Infectious Diseases Market Size by Type (2016-2020) (Million US$)
Table Global Infectious Diseases Market Size Share by Type (2016-2020)
Figure Global Infectious Diseases Market Size Market Share by Type (2016-2020)
Table Global Infectious Diseases Market Size by Application (2016-2020) (Million US$)
Table Global Infectious Diseases Market Size Share by Application (2016-2020)
Figure Global Infectious Diseases Market Size Market Share by Application (2016-2020)
Figure Global Infectious Diseases Revenue Market Share by Application in 2020
Figure United States Infectious Diseases Market Size 2016-2020 (Million US$)
Table United States Key Players Infectious Diseases Revenue (2020) (Million US$)
Table United States Key Players Infectious Diseases Market Share (2020)
Table United States Infectious Diseases Market Size by Type (2016-2020) (Million US$)
Table United States Infectious Diseases Market Share by Type (2016-2020)
Table United States Infectious Diseases Market Size by Application (2016-2020) (Million US$)
Table United States Infectious Diseases Market Share by Application (2016-2020)
Figure Europe Infectious Diseases Market Size 2016-2020 (Million US$)
Table Europe Key Players Infectious Diseases Revenue (2020) (Million US$)
Table Europe Key Players Infectious Diseases Market Share (2020)
Table Europe Infectious Diseases Market Size by Type (2016-2020) (Million US$)
Table Europe Infectious Diseases Market Share by Type (2016-2020)
Table Europe Infectious Diseases Market Size by Application (2016-2020) (Million US$)
Table Europe Infectious Diseases Market Share by Application (2016-2020)
Figure China Infectious Diseases Market Size 2016-2020 (Million US$)
Table China Key Players Infectious Diseases Revenue (2020) (Million US$)
Table China Key Players Infectious Diseases Market Share (2020)
Table China Infectious Diseases Market Size by Type (2016-2020) (Million US$)
Table China Infectious Diseases Market Share by Type (2016-2020)
Table China Infectious Diseases Market Size by Application (2016-2020) (Million US$)
Table China Infectious Diseases Market Share by Application (2016-2020)
Figure Japan Infectious Diseases Market Size 2016-2020 (Million US$)
Table Japan Key Players Infectious Diseases Revenue (2020) (Million US$)
Table Japan Key Players Infectious Diseases Market Share (2020)
Table Japan Infectious Diseases Market Size by Type (2016-2020) (Million US$)
Table Japan Infectious Diseases Market Share by Type (2016-2020)
Table Japan Infectious Diseases Market Size by Application (2016-2020) (Million US$)
Table Japan Infectious Diseases Market Share by Application (2016-2020)
Figure Southeast Asia Infectious Diseases Market Size 2016-2020 (Million US$)
Table Southeast Asia Key Players Infectious Diseases Revenue (2020) (Million US$)
Table Southeast Asia Key Players Infectious Diseases Market Share (2020)
Table Southeast Asia Infectious Diseases Market Size by Type (2016-2020) (Million US$)
Table Southeast Asia Infectious Diseases Market Share by Type (2016-2020)
Table Southeast Asia Infectious Diseases Market Size by Application (2016-2020) (Million US$)
Table Southeast Asia Infectious Diseases Market Share by Application (2016-2020)
Figure India Infectious Diseases Market Size 2016-2020 (Million US$)
Table India Key Players Infectious Diseases Revenue (2020) (Million US$)
Table India Key Players Infectious Diseases Market Share (2020)
Table India Infectious Diseases Market Size by Type (2016-2020) (Million US$)
Table India Infectious Diseases Market Share by Type (2016-2020)
Table India Infectious Diseases Market Size by Application (2016-2020) (Million US$)
Table India Infectious Diseases Market Share by Application (2016-2020)
Figure Central & South America Infectious Diseases Market Size 2016-2020 (Million US$)
Table Central & South America Key Players Infectious Diseases Revenue (2020) (Million US$)
Table Central & South America Key Players Infectious Diseases Market Share (2020)
Table Central & South America Infectious Diseases Market Size by Type (2016-2020) (Million US$)
Table Central & South America Infectious Diseases Market Share by Type (2016-2020)
Table Central & South America Infectious Diseases Market Size by Application (2016-2020) (Million US$)
Table Central & South America Infectious Diseases Market Share by Application (2016-2020)
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Revenue in Infectious Diseases Business (2020) (Million US$)
Figure F. Hoffmann-La Roche Revenue Growth Rate in Infectious Diseases Business (2020)
Table F. Hoffmann-La Roche Recent Development
Table Gilead Sciences Company Details
Table Gilead Sciences Revenue in Infectious Diseases Business (2020)(Million US$)
Figure Gilead Sciences Revenue Growth Rate in Infectious Diseases Business (2020)
Table Gilead Sciences Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Infectious Diseases Business (2020)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Infectious Diseases Business (2020)
Table GlaxoSmithKline Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Infectious Diseases Business (2020)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Infectious Diseases Business (2020)
Table Johnson & Johnson Recent Development
Table Merck Company Details
Table Merck Revenue in Infectious Diseases Business (2020)(Million US$)
Figure Merck Revenue Growth Rate in Infectious Diseases Business (2020)
Table Merck Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Infectious Diseases Business (2020)(Million US$)
Figure Pfizer Revenue Growth Rate in Infectious Diseases Business (2020)
Table Pfizer Recent Development
Table AbbVie Company Details
Table AbbVie Revenue in Infectious Diseases Business (2020)(Million US$)
Figure AbbVie Revenue Growth Rate in Infectious Diseases Business (2020)
Table AbbVie Recent Development
Table Astellas Pharma Company Details
Table Astellas Pharma Revenue in Infectious Diseases Business (2020)(Million US$)
Figure Astellas Pharma Revenue Growth Rate in Infectious Diseases Business (2020)
Table Astellas Pharma Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Infectious Diseases Business (2020)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Infectious Diseases Business (2020)
Table AstraZeneca Recent Development
Table Bayer Company Details
Table Bayer Revenue in Infectious Diseases Business (2020)(Million US$)
Figure Bayer Revenue Growth Rate in Infectious Diseases Business (2020)
Table Bayer Recent Development
Table Bristol-Myers Squibb Company Details
Table Chimerix Pharmaceuticals Company Details
Table Cubist Company Details
Table Eli Lilly Company Details
Table Isis Pharmaceuticals Company Details
Table Mitsubishi Tanabe Pharma Company Details
Table Novartis Company Details
Table Sanofi Company Details
Table Vertex Company Details
Table Global Infectious Diseases Market Size by Regions (Million US$) 2021-2027
Figure Global Infectious Diseases Market Size Share by Regions (2021-2027)
Figure Global Infectious Diseases Market Size Share by Regions in 2027
Figure United States Infectious Diseases Market Size Forecast (2021-2027)(Million USD)
Figure Europe Infectious Diseases Market Size Forecast (2021-2027)(Million USD)
Figure China Infectious Diseases Market Size Forecast (2021-2027)(Million USD)
Figure Japan Infectious Diseases Market Size Forecast (2021-2027)(Million USD)
Figure Southeast Asia Infectious Diseases Market Size Forecast (2021-2027)(Million USD)
Figure India Infectious Diseases Market Size Forecast (2021-2027)(Million USD)
Figure Central & South America Infectious Diseases Market Size Forecast (2021-2027)(Million USD)
Table Global Infectious Diseases Market Size by Product (2021-2027) (Million US$)
Figure Global Infectious Diseases Market Size by Product (2021-2027)
Figure Global Infectious Diseases Market Size by Product in 2027
Table Global Infectious Diseases Market Size by Application (2021-2027) (Million US$)
Figure Global Infectious Diseases Market Size by Application (2021-2027)
Figure Global Infectious Diseases Market Size by Application in 2027
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources